{
    "title": "Adoptive T cell therapy: Boosting the immune system to fight cancer.",
    "doc_id": "33262066",
    "writer": "Leon E",
    "year": "2020",
    "summary": "Encouraging results against hematologic malignancies are paving the way to move into solid tumors. In this review, we will focus on T-cell therapies starting from tumor infiltrating lymphocytes (TILs) to optimized T-cell receptor-modified (TCR) cells a â€¦",
    "abstract": "Cellular therapies have shown increasing promise as a cancer treatment. Encouraging results against hematologic malignancies are paving the way to move into solid tumors. In this review, we will focus on T-cell therapies starting from tumor infiltrating lymphocytes (TILs) to optimized T-cell receptor-modified (TCR) cells and chimeric antigen receptor-modified T cells (CAR-Ts). We will discuss the positive preclinical and clinical findings of these approaches, along with some of the persisting barriers that need to be overcome to improve outcomes.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/33262066/",
    "clean_text": "adoptive t cell therapy boosting the immune system to fight cancer encouraging results against hematologic malignancies are paving the way to move into solid tumors in this review we will focus on t cell therapies starting from tumor infiltrating lymphocytes tils to optimized t cell receptor modified tcr cells a cellular therapies have shown increasing promise as a cancer treatment encouraging results against hematologic malignancies are paving the way to move into solid tumors in this review we will focus on t cell therapies starting from tumor infiltrating lymphocytes tils to optimized t cell receptor modified tcr cells and chimeric antigen receptor modified t cells car ts we will discuss the positive preclinical and clinical findings of these approaches along with some of the persisting barriers that need to be overcome to improve outcomes"
}